TRT surprises on TikTok: what the science says about testosterone

What did @popethecoach actually say?

He's 29 weeks into testosterone replacement therapy, still dealing with acne and midday fatigue, and recently switched clinics after concluding he was being treated incorrectly. His core claim: "after being on testosterone for over half a year, there's no reason I should be getting side effects like acne or even wanting to take a nap halfway through the day." He's also implying that better protocol management could have prevented these issues from the start.

To be clear, he's not presenting himself as a medical authority. He's a patient who feels let down by his previous clinic and is sharing that experience. That framing matters when evaluating what he gets right and wrong, because some of what he's frustrated about is clinically legitimate, and some of it is more complicated than he's suggesting.

Does the science back this up?

Partly, yes. Persistent acne and fatigue after six months on TRT are real red flags worth investigating, but they're not automatic proof of poor clinical management. Both symptoms can have multiple causes, and "better treatment" isn't always the answer.

Acne on TRT is driven by androgens stimulating sebaceous glands. If a patient's testosterone dose is too high, or their estradiol and DHT conversion is unmanaged, acne is a predictable result. A 2020 study by Rastrelli, Corona, and Maggi in the journal Best Practice and Research Clinical Endocrinology and Metabolism noted that dermatological side effects like acne are among the most common reasons patients discontinue TRT, and that dose optimization significantly reduces incidence. So he's right that persistent acne after six months suggests something may need adjusting.

Fatigue is trickier. TRT can actually cause fatigue if hematocrit rises too high, if sleep apnea develops or worsens, or if dosing timing creates hormonal peaks and troughs. A 2019 review by Bhasin et al. in the New England Journal of Medicine specifically lists erythrocytosis and sleep-disordered breathing as underrecognized contributors to fatigue in men on TRT. A new clinic and a better protocol might help, but without knowing his hematocrit, estradiol levels, and injection schedule, it's genuinely impossible to say the old clinic was simply negligent.

What did they get wrong (or right)?

He gets credit for recognizing that persistent symptoms after six-plus months aren't something to just accept. That instinct is clinically reasonable. TRT protocols should be reviewed and adjusted based on follow-up bloodwork, typically at 3 and 6 months, according to the American Urological Association's 2018 guidelines on testosterone deficiency.

Where he oversimplifies: the claim that there's "no reason" he should have side effects after this long is too absolute. Some men on TRT require ongoing management of estradiol conversion with aromatase inhibitors. Some need DHT management. Some have genetic predispositions to acne that testosterone simply amplifies regardless of protocol quality. And fatigue has a long differential even in men whose testosterone levels are optimized.

The bigger concern is the implicit message that switching clinics and adjusting dose will fix everything. That may be true in his case. It may not. Without knowing what his bloodwork actually shows, including total testosterone, free testosterone, estradiol, hematocrit, and SHBG, nobody can say his old clinic was wrong and his new one will be right. That's not a knock on him. It's just context his audience needs and isn't getting.

What should you actually know?

If you're on TRT and still experiencing significant side effects at the six-month mark, that is worth a conversation with your prescriber. It is not automatically proof that your clinic is incompetent, but it is a signal that your protocol may need review.

Side effects like acne and fatigue on TRT typically have identifiable, measurable causes. Acne often correlates with elevated androgens or suboptimal estradiol management. Fatigue can reflect elevated hematocrit, injection timing issues, or worsening sleep apnea. A thorough lab panel can usually point toward the cause. The AUA and Endocrine Society both recommend follow-up labs at 3 months after initiation and every 6 to 12 months thereafter once stable.

Switching clinics is sometimes the right move, especially if a provider isn't monitoring labs regularly or isn't responsive to symptom reports. But the new clinic still needs to work from your actual bloodwork, not just reassure you that you'll get better treatment. Ask specifically what they plan to monitor, how often, and what thresholds would prompt a dose adjustment. Those are reasonable questions any legitimate TRT provider should answer directly.